All In MedTech

FDA Clearance Tracker · P790007

HANCOCK MODIFIED ORIFICE BIOPROSTHESIS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Nov 15, 1979 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Nov 15, 1979

Approved

Time to decision

267 days

Received Feb 21, 1979. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P790007
Device name
HANCOCK MODIFIED ORIFICE BIOPROSTHESIS
Applicant location
Santa Ana, CA
Received
Feb 21, 1979
Decided
Nov 15, 1979
Decision
Approved
Supplements
62 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LWR

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LWR (heart-valve, non-allograft tissue).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medtronic Heart Valves

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.